ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,489Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 1454

$1.55M Total Retail Price of All Prescriptions

Rank: 22 out of 1454

740 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 740 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 740 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 15,210 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 1,010 782 1 1
OMEPRAZOLE 798 514 2 3
HYDROCODONE-ACETAMINOPHEN 670 403 S3 3 7
LEVOTHYROXINE SODIUM 530 426 4 5
FUROSEMIDE 509 386 5 6
ZOLPIDEM TARTRATE 491 312 6 19
AMLODIPINE BESYLATE 488 376 7 2
LISINOPRIL 436 338 8 4
CARVEDILOL 412 324 9 24
ATORVASTATIN CALCIUM 386 275 10 11
ALENDRONATE SODIUM 373 288 11 35
HYDROCHLOROTHIAZIDE 356 253 12 9
METFORMIN HCL 343 229 13 8
NEXIUM 333 164 14 23
ALLOPURINOL 319 227 15 28
OXYCODONE HCL 293 63 S2 16 80
GABAPENTIN 288 171 17 16
METFORMIN HCL ER 253 158 18 41
CLOPIDOGREL 244 168 19 32
LOVASTATIN 242 211 20 39
TRAMADOL HCL 216 148 21 20
SERTRALINE HCL 215 145 22 26
DONEPEZIL HCL 205 182 23 29
PRAVASTATIN SODIUM 204 138 24 12
LOSARTAN POTASSIUM 196 154 25 14
PROAIR HFA 193 102 26 56
CITALOPRAM HBR 192 145 27 21
GLIMEPIRIDE 192 139 27 33
ENALAPRIL MALEATE 189 146 29 58
CYMBALTA 185 85 30 55
POTASSIUM CHLORIDE 185 111 30 15
METOPROLOL TARTRATE 181 145 32 10
JANUVIA 171 113 33 77
TRAMADOL HCL-ACETAMINOPHEN 167 159 34 165
MELOXICAM 167 123 34 37
ZOSTAVAX 164 132 36 195
FENOFIBRATE 163 121 37 68
CRESTOR 158 66 38 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 157 115 39 27
OXYCODONE HCL-ACETAMINOPHEN 150 48 S2 40 93
PLAVIX 149 116 41 45
CELEBREX 147 85 42 81
METOPROLOL SUCCINATE 146 97 43 13
LYRICA 145 41 44 103
DIOVAN 145 116 44 40
WARFARIN SODIUM 144 122 46 17
CARISOPRODOL 142 14 R 47 123
TRIAMTERENE-HCTZ 137 87 48 44
TRAZODONE HCL 137 50 48 50
AZITHROMYCIN 133 82 50 42
GLIPIZIDE ER 131 117 51 92
CYCLOBENZAPRINE HCL 131 76 R 51 59
PROMETHAZINE HCL 131 64 R 51 82
GLIPIZIDE XL 126 107 54 85
FLUTICASONE PROPIONATE 126 66 54 30
OXYCODONE-ACETAMINOPHEN 121 75 S2 56 60
MIRTAZAPINE 121 76 56 53
SPIRIVA 120 71 58 52
MORPHINE SULFATE ER 116 12 S2 59 181
PAROXETINE HCL 113 102 60 73
RAMIPRIL 113 105 60 66
TAMSULOSIN HCL 110 87 62 34
OXYCONTIN 109 29 S2 63 173
ISOSORBIDE MONONITRATE ER 108 76 64 46
ADVAIR DISKUS 107 69 65 47
ATENOLOL 102 74 66 18
VENTOLIN HFA 102 51 66 112
TRICOR 97 47 68 134
GLIPIZIDE 96 60 69 62
SYNTHROID 94 66 70 25
KLOR-CON M20 94 90 70 54
PANTOPRAZOLE SODIUM 93 69 72 31
DOXEPIN HCL 91 48 73 234
AMITRIPTYLINE HCL 90 58 R 74 71
FENTANYL 84 36 S2 75 104
NAMENDA 83 79 76 48
BYSTOLIC 82 58 77 110
LEVOXYL 81 51 78 84
AMLODIPINE BESYLATE-BENAZEPRIL 81 81 78 65
ESCITALOPRAM OXALATE 81 35 78 78
HYDROXYZINE HCL 80 37 R 81 183
CEFDINIR 80 53 81 182
JANUMET 79 50 83 238
LIPITOR 77 60 84 74
ESTRADIOL 75 37 R 85 164
IBUPROFEN 75 45 85 107
PREDNISONE 75 36 85 36
QUETIAPINE FUMARATE 74 40 88 91
ROPINIROLE HCL 74 46 88 96
ENDOCET 73 15 S2 90 137
RANITIDINE HCL 69 39 91 43
DILTIAZEM 24HR CD 67 37 92 76
ACTONEL 66 49 93 266
SINGULAIR 65 22 94 83
FINASTERIDE 62 50 95 94
NAPROXEN 62 41 95 122
FLUCONAZOLE 61 28 97 160
LANTUS 60 31 98 51
ANDROGEL 60 23 S3 98 443
BENAZEPRIL HCL 58 45 100 57
LANTUS SOLOSTAR 56 34 101 79
VYTORIN 56 35 101 170
PHENYTOIN SODIUM EXTENDED 55 27 103 138
OLANZAPINE 55 36 103 163
SYMBICORT 55 25 103 143
DICLOFENAC SODIUM 55 31 103 118
DIOVAN HCT 54 46 107 75
ATENOLOL-CHLORTHALIDONE 53 46 108 203
METOCLOPRAMIDE HCL 53 32 108 121
GLYBURIDE-METFORMIN HCL 52 43 R 110 139
OXYBUTYNIN CHLORIDE ER 52 52 110 156
TESTOSTERONE CYPIONATE 52 27 S3 110 360
LEVEMIR FLEXPEN 50 22 113 171
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.